| BCBS Highmark West Virginia | Non-Surgical Management of Nasal Airway Obstruction | 2026-03-02 |
| BCBS Highmark West Virginia | Experimental/Investigational Services | 2026-03-02 |
| BCBS Highmark West Virginia | GI Effects Comprehensive Stool Profile | 2026-03-02 |
| BCBS Highmark West Virginia | ProAct: Adjustable Continence Therapy for Men | 2026-03-02 |
| BCBS Highmark West Virginia | Mosunetuzumab-axgb (Lunsumio) and mosunetuzumab-axgb (Lunsumio Velo) | 2026-03-02 |
| BCBS Highmark West Virginia | Chimeric Antigen Receptor T-Cell and T-Cell Receptor Therapies | 2026-03-02 |
| BCBS Highmark West Virginia | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-03-02 |
| BCBS Highmark West Virginia | Intravitreal Injections | 2026-03-02 |
| BCBS Highmark West Virginia | Amivantamab-vmjw (Rybrevant) and Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | 2026-03-02 |
| UHC Medicare Advantage | Category III CPT Codes - Medicare Advantage Medical Policy | 2026-03-01 |